Plasma free and conjugated catecholamines in clinical disorders

Area of Science:

• Biochemistry
• Endocrinology
• Pharmacology

Background:

• Catecholamines (CA) like norepinephrine (NE), epinephrine (E), and dopamine (DA) exist in free and sulfoconjugated forms in plasma.
• Understanding the regulation of CA sulfation is crucial for interpreting their physiological and pathological roles.

Purpose of the Study:

• To investigate plasma concentrations of free and sulfoconjugated catecholamines in various patient populations and healthy controls.
• To explore factors influencing catecholamine sulfation and the balance between free and conjugated forms.

Main Methods:

• Measurement of plasma free and sulfoconjugated NE, E, and DA.
• Comparison of catecholamine levels in healthy volunteers, patients with thrombocytopenia/thrombocytosis, newborns, pregnant women, liver failure patients, and those undergoing intracardiac procedures.
• Analysis of catecholamine ratios in hypothyroid patients and those with pheochromocytoma or myocardial infarction.

Main Results:

• Plasma free and sulfoconjugated catecholamine levels were similar in healthy controls, thrombocytopenic/thrombocytotic patients, newborns, and pregnant women.
• Liver failure patients exhibited significantly higher free and conjugated NE and E levels compared to controls.
• The percentage of free catecholamines was significantly lower in hypothyroid patients compared to controls.

Conclusions:

• Catecholamine sulfation is not solely dependent on platelets, liver, vascular beds, or organs along the vena cava.
• A balance exists between free and sulfated catecholamines, influenced by age and conditions like pheochromocytoma or heart attack.
• Hypothyroidism significantly impacts the balance of free to conjugated catecholamines through an undetermined mechanism.